Publisher
Springer Science and Business Media LLC
Reference5 articles.
1. World Health Organization. Saturated Fatty Acid and Trans-Fatty Acid Intake for Adults and Children: WHO Guideline (World Health Organization, 2023). The updated WHO guidelines provide a comprehensive synthesis and evaluation of evidence for effects of reduced saturated fat intake on cardiovascular disease risk.
2. Schulze, M. B. et al. Intake and metabolism of omega-3 and omega-6 polyunsaturated fatty acids: nutritional implications for cardiometabolic diseases. Lancet Diabetes Endocrinol. 8, 915–930 (2020). A review of the evidence and potential mechanisms that link polyunsaturated fat intake and metabolism to cardiometabolic health.
3. Morze, J. et al. Metabolomics and type 2 diabetes risk: an updated systematic review and meta-analysis of prospective cohort studies. Diabetes Care 45, 1013–1024 (2022). This meta-analyses shows that most of the 123 diabetes-associated metabolites are lipids, highlighting the role of fat intake and lipid metabolism.
4. Wittenbecher, C. et al. Dihydroceramide- and ceramide-profiling provides insights into human cardiometabolic disease etiology. Nat. Commun. 13, 936 (2022). This article examines ceramide networks as mediators of diet–cardiometabolic risk associations.
5. Eichelmann, F. et al. Deep lipidomics in human plasma: cardiometabolic disease risk and effect of dietary fat modulation. Circulation 146, 21–35 (2022). A lipidome-wide association study of type 2 diabetes and cardiovascular disease incidence.